Mar-Afatinib 30 mg

Afatinib (afatinib dimaleate) 30 mg tablets are a targeted therapy used to treat certain types of cancer. This oral medication is designed to inhibit specific enzymes involved in cancer cell growth.

Afatinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) and other advanced cancers. It works by targeting and blocking proteins that promote cancer cell proliferation. Patients often wonder, 'What is afatinib used for?' This medication is typically prescribed for conditions where these proteins are overactive, contributing to tumor growth.

Common effects of afatinib may include skin rash, diarrhea, and fatigue. Some users also report nausea and decreased appetite. These effects can vary in severity and duration among individuals.

Afatinib should be handled with care, following the guidance of a healthcare provider. It is important to monitor for severe side effects and report any unusual symptoms. Pregnant women and those with certain medical conditions should discuss potential risks with their doctor.

Afatinib may interact with other medications, including those metabolized by the liver. It is advisable to avoid grapefruit products, as they can affect the metabolism of afatinib. Always inform your healthcare provider about all medications you are taking.